Comentis

Pharma company focused on research and development for Neurovascular disease

placeSan Francisco, California, United States calendar_todayFounded 2004 groups33 employees language comentis.com

Innovation

16 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 1,283 times.

YearFilings
20127
20133
20141
20151
20162
20171

Investor mix

12 investors on record; lead investors include Sanderling Ventures.

Investor typeCountShare
Venture capital975%
Private equity217%
Angel & family office18%
Coming soon